Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis

Tuberculosis (TB) remains a major health problem throughout the world with one third of the population latently infected and ~1.74 million deaths annually. Current therapy consists of multiple antibiotics and a lengthy treatment regimen, which is associated with risk for the generation of drug-resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dhiraj Kumar, Tousif, Sultan, Bhaskar, Ashima, Devi, Annu, Negi, Kriti, Moitra, Barnani, Ranganathan, Anand, Dwivedi, Ved Prakash, Das, Gobardhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409628/
https://www.ncbi.nlm.nih.gov/pubmed/34415976
http://dx.doi.org/10.1371/journal.ppat.1009805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409628/
https://www.ncbi.nlm.nih.gov/pubmed/34415976
http://dx.doi.org/10.1371/journal.ppat.1009805

Ejemplares similares